Healthcare firm AstraZeneca Pharma India Friday reported a threefold jump in its net profit to Rs 9.82 crore in the quarter ended March 31.
The company had posted a net profit of Rs 3.22 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to the BSE.
Its total income stood at Rs 196.31 crore in the quarter, compared with Rs 153.06 crore a year ago.
For the fiscal year ended March this year, the company's net profit rose to Rs 54.44 crore as against Rs 25.91 crore for the previous fiscal year.
The firm's total income stood at Rs 744.57 crore for the fiscal year ended March 2019. It was Rs 584.23 crore in the previous financial year.
Shares of AstraZeneca Pharma India closed at Rs 2,197.65 per scrip on the BSE, down 1.18 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app